A comprehensive view of Injectables / Infusions / IV Drips. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Merck receives positive EU CHMP opinion for KEYTRUDA and Padcev for first-line treatment of unresectable or metastatic urothelial carcinoma; based on Phase 3 KEYNOTE-A39 trial results
Published: July 26, 2024 by Merck & Co. Inc.
Researchers Submit Patent Application, 'Methods Of In Vitro Dissolution', for Approval (USPTO 20240226821)
Published: July 26, 2024 by NewsRx Pharma Business Daily
Pfizer announces positive Phase 3 results for hemophilia A gene therapy giroctocogene fitelparvovec; trial shows a significant reduction in mean total annualized bleeding rate
Published: July 24, 2024 by Pfizer Inc.
Becton, Dickinson & Co. introduces Phasix™ ST Mesh and PIVO™ Pro; innovations in hernia repair and IV therapy aim to enhance surgical precision, reduce time, and improve patient care
Published: July 19, 2024 by Industry Intelligence Inc.
Roche's Susvimo shows sustained efficacy over two years in Phase III diabetic eye studies; FDA accepts application for diabetic macular edema and retinopathy treatments based on one-year results
Published: July 18, 2024 by F. Hoffmann-La Roche Ltd. (Roche)

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count